Overcoming Drug Resistance in Gynecologic Cancers provides up-to-date information related to important gynecologic cancers and focuses on mechanisms of drug resistance, genetics, signaling, immunology, health disparities, nanotechnology, economic considerations and financial impacts. The book covers not only drug resistance but also important means to reverse resistance both in the laboratory and clinic. The book discusses topics such as lifestyle, nutrition and risk of gynecologic cancers, the financial impact of drug resistance, chemosensitizing agents and targeted therapies in cervical, endometrial and ovarian cancer, immunotherapy to overcome drug resistance, and genetic polymorphisms in gynecologic cancers. Additionally, it discusses ethnic and racial health disparity perspectives and future developments in chemosensitizing activities to reverse drug resistance in gynecologic cancers. It is a valuable resource for cancer researchers, oncologists, clinicians and other biomedical field members who are interested in new approaches to improve chemotherapy outcome in patients with gynecologic cancers.

Provides an interdisciplinary approach to the subject of Environment and health integrating biochemical, physiological, pharmacological, toxicological, behavioral and ecological responses to different types of environmental challenges. The information presented provides modern molecular insights into mechanistic basis of environmental health effects of various environmental toxicants including prevention and therapeutics. This volume with contributions from highly reputed and well known experts from USA, Kuwait, Australia, Sweden and, India is a valuable source of information for researchers working in the interdisciplinary areas of Environmental Health Science.